Sub menu

 

 

Australian Public Assessment Reports (AusPAR)

Search our AusPAR dataset for information on the evaluation of prescription medicines.

Use the filters below to narrow your search.

Filter results

You can narrow down the results using the filters.

Sponsor

Topics

AusPAR Date

An AusPAR provides information about the evaluation of a prescription medicine and the considerations that led the TGA to approve or not approve an application.

For more information see Australian Public Assessment Reports for prescription medicines (AusPARs).

1143 result(s) found, displaying 851 to 875

  • AusPAR: Adalimumab (rch)

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Adalimumab (rch)

  • AusPAR: Interferon beta-1a

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Interferon beta-1a

  • AusPAR: Pertuzumab (rch)

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Pertuzumab (rch)

  • AusPAR: Nabiximols

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Nabiximols

  • AusPAR: Rivaroxaban

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Rivaroxaban

  • AusPAR: Botulinum toxin type A

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Botulinum toxin type A

  • AusPAR: Dimethyl fumarate

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Dimethyl fumarate

  • AusPAR: Atazanavir

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Atazanavir

  • AusPAR: Retigabine

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Retigabine

  • AusPAR: Clobazam

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Clobazam

  • AusPAR: Eplerenone

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Eplerenone

  • AusPAR: Filgrastim (rbe)

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Filgrastim (rbe)

  • AusPAR: Rivaroxaban

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Rivaroxaban

  • AusPAR: Cetuximab

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Cetuximab

  • AusPAR: Fidaxomicin

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Fidaxomicin

  • AusPAR: Linagliptin

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Linagliptin

  • AusPAR: Terlipressin

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Terlipressin

  • AusPAR: Vismodegib

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Vismodegib

  • AusPAR: IVIg

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for IVIg

  • AusPAR: Pitavastatin

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Pitavastatin

  • AusPAR: Rituximab

    Australian public assessment report (AusPar)
    Australian Public Assessment Report for Rituximab